Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ertapenem pharmacokinetics and pharmacodynamics in adult patients with tuberculosis
NL-OMON43693Phase 2Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ertapenem in Tuberculosis (TB), sponsored by University Medical Center Groningen. Primary endpoint: Pharmacokinetics of ertapenem. Started Jan 2017; status: active, not recruiting.
02
Drugs
ertapenem
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NL-OMON43693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43693.